ReviewBritish journal of cancer2013

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor.

Y Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.